FDA Clearance Tracker · P250012
Simplera Sync Sensor, Guardian 4 Sensor
Last checked: Nov 19, 2026Latest source record: Aug 6, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Aug 6, 2025
Approved
Time to decision
110 days
Received Apr 18, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P250012
- Device name
- Simplera Sync Sensor, Guardian 4 Sensor
- Applicant
- Medtronic Minimed, Inc.
- Applicant location
- Northridge, CA
- Received
- Apr 18, 2025
- Decided
- Aug 6, 2025
- Decision
- Approved
- Supplements
- 11 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of the Simplera Sync sensor and Guardian 4 sensor, intended to function as components of a Medtronic automated insulin dosing system.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code SFI (Sensor, Glucose, Invasive, Component of automated insulin delivery system).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medtronic Minimed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MiniMed Flex pump510(k)
K253743 · Decided Mar 12, 2026 · 108 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
K253470 · Decided Jan 15, 2026 · 97 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
K253585 · Decided Jan 14, 2026 · 58 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.